NVS Clinical trials New Novartis ESC data highlights strength of cardiovascular portfolio Published August 18, 2025 at 05:15 AM PRESS RELEASE Related Questions What is the expected market reaction to the strengthened cardiovascular portfolio? How does this data position Novartis against competitors in the cardiovascular space? How will the new ESC data affect Novartis' upcoming earnings forecasts? Find similar articles on Candlesense globenewswire